(19)

(11)

EP 4 384 158 A1

(12)

(43) Date of publication: 19.06.2024 Bulletin 2024/25 (21) Application number: 22856497.7 (22) Date of filing: 09.08.2022

(51) International Patent Classification (IPC):  A61K 31/33(2006.01) A61K 31/395(2006.01) A61K 9/14(2006.01) A61K 31/4178(2006.01) A61K 9/16(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/4178; A61K 31/216; A61K 9/5078; A61K 9/5084; A61K 9/1676   C-Sets: A61K 31/4178, A61K 2300/00; A61K 31/216, A61K 2300/00; (86) International application number: PCT/US2022/039822 (87) International publication number: WO 2023/018709 (16.02.2023 Gazette 2023/07)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 11.08.2021 US 202163260154 P (71) Applicant: TheraVida, Inc. Chapel Hill, NC 27517 (US)	(72) Inventors: ANDREWS, Stephen Wayne Raleigh, North Carolina 27613 (US) BALIK, Samuel Bruce Raleigh, North Carolina 27612 (US) JETT, John Edward Pittsboro, North Carolina 27312 (US) LEMING, Robert Michael Morganton, North Carolina 28655 (US) (74) Representative: Bassil, Nicholas Charles  Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)